학술논문

Focal Lesions of the Liver and Radiomics: What Do We Know?
Document Type
Article
Source
Diagnostics (2075-4418). Aug2023, Vol. 13 Issue 15, p2591. 15p.
Subject
*CONTRAST-enhanced magnetic resonance imaging
*RADIOMICS
*POSITRON emission tomography
*LIVER
*COMPUTED tomography
*FATTY liver
Language
ISSN
2075-4418
Abstract
Despite differences in pathological analysis, focal liver lesions are not always distinguishable in contrast-enhanced magnetic resonance imaging (MRI), contrast-enhanced computed tomography (CT), and positron emission tomography (PET). This issue can cause problems of differential diagnosis, treatment, and follow-up, especially in patients affected by HBV/HCV chronic liver disease or fatty liver disease. Radiomics is an innovative imaging approach that extracts and analyzes non-visible quantitative imaging features, supporting the radiologist in the most challenging differential diagnosis when the best-known methods are not conclusive. The purpose of this review is to evaluate the most significant CT and MRI texture features, which can discriminate between the main benign and malignant focal liver lesions and can be helpful to predict the response to pharmacological or surgical therapy and the patient's prognosis. [ABSTRACT FROM AUTHOR]